Physician profile
Christopher A Orlando
NPI 1093793093
$2,509.73
in general payments reported to CMS, 2019-2025
15 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $675 · 2021: $250 · 2022: $280 · 2023: $677 · 2024: $256 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,305.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $373.55 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $360.96 | 2021-2025 | Nuzyra |
| Advanced Oxygen Therapy INC. | $344.27 | 2022-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Medtronic, INC. | $195.72 | 2023 | Intellis Adaptivestim |
| Cequr Corporation | $190.91 | 2022 | |
| Spr Therapeutics, INC | $141.39 | 2025 | Sprint Pns System |
| Organogenesis INC. | $124.99 | 2019 | |
| Mannkind Corporation | $124.14 | 2023 | Afrezza |
| Lilly USA, LLC | $122.07 | 2023 | Mounjaro |
| Novo Nordisk INC | $120.00 | 2023 | |
| Amgen INC. | $110.77 | 2025 | Krystexxa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $93.15 | 2019 | |
| Cardiovascular Systems INC. | $83.33 | 2019 | |
| Becton, Dickinson and Company | $68.16 | 2019 | |
| Ekos Corporation | $56.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Orlando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.